The importance of children and young person involvement in scoping the need for a paediatric glucocorticoid-associated patient reported outcome measure.

Singhal, S; Smith, E M D; Roper, L; Pain, C E

Singhal, S; Smith, E M D; Roper, L; Pain, C E.

Affiliation

Singhal S; Institute in the Park, Alder Hey Children's Hospital, Institute of Life Course and Medical Sciences, University of Liverpool, Eaton Rd, Liverpool, L12 2AP, UK.
Smith EMD; Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
Roper L; Institute in the Park, Alder Hey Children's Hospital, Institute of Life Course and Medical Sciences, University of Liverpool, Eaton Rd, Liverpool, L12 2AP, UK. esmith8@liverpool.ac.uk.
Pain CE; Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK. esmith8@liverpool.ac.uk.

BMC Rheumatol ; 6(1): 80, 2022 Oct 15.

Article de En | MEDLINE | ID: mdl-36243873

Mots clés

Children and young people; Glucocorticoid; Patient and public involvement; Patient reported outcome

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Qualitative_research / Risk_factors_studies Aspects: Patient_preference Langue: En Journal: BMC Rheumatol Année: 2022 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google